SyntheticMR Receives Regulatory Approval for SyMRI in Taiwan
SyntheticMR announced today that its quantitative imaging software solution, SyMRI 12, has received regulatory approval from the Taiwan Food and Drug Administration (TFDA). This milestone enables the sale and distribution of SyMRI 12 in the Taiwanese market, paving the way for regional expansion. "This approval of SyMRI 12 opens new opportunities for us to expand our market presence in Taiwan and the Southeast Asia region. We are excited to offer SyMRI 12 to radiologists in this market, providing them with new insights and enhancing their practice through our unique technology and